Sino Biological,Inc. (SHE:301047)
73.72
+0.26 (0.35%)
Last updated: Aug 25, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Recombinant Protein | 273.11M | Log In | Log In | Log In | Log In | Upgrade |
Recombinant Protein Growth | 6.87% | Log In | Log In | Log In | Log In | Upgrade |
Contract Research Organization Services | 168.53M | Log In | Log In | Log In | Log In | Upgrade |
Contract Research Organization Services Growth | 9.40% | Log In | Log In | Log In | Log In | Upgrade |
Antibody | 106.49M | Log In | Log In | Log In | Log In | Upgrade |
Antibody Growth | -41.20% | Log In | Log In | Log In | Log In | Upgrade |
Culture Medium | 28.23M | Log In | Log In | Log In | Log In | Upgrade |
Culture Medium Growth | 2.05% | Log In | Log In | Log In | Log In | Upgrade |
Housing Rental and Supporting Facilities | 26.38M | Log In | Log In | Log In | Log In | Upgrade |
Housing Rental and Supporting Facilities Growth | 70.84% | Log In | Log In | Log In | Log In | Upgrade |
Gene | 8.55M | Log In | Log In | Log In | Log In | Upgrade |
Gene Growth | -27.35% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.38M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 197.06% | Log In | Log In | Log In | Log In | Upgrade |
Other | 2.38M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 197.06% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Overseas | 354.36M | Log In | Log In | Log In | Log In | Upgrade |
Overseas Growth | -11.66% | Log In | Log In | Log In | Log In | Upgrade |
China | 259.31M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | 5.72% | Log In | Log In | Log In | Log In | Upgrade |
United States | - | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |